“HLA-A*0201-restricted VEGFR1 peptide vaccine”的概念、定义、翻译、参考文献-科学参考

A cancer vaccine containing an HLA-A*0201-restricted vascular endothelial growth factor receptor 1 (VEGFR1) peptide (sequence: TLFWLLLTL) with potential immunostimulatory and antitumor activities. Upon administration, HLA-A*0201-restricted VEGFR1-derived peptide vaccine may stimulate a cytotoxic T lymphocyte (CTL) response against tumor cells expressing VEGFR1, resulting in tumor cell lysis and decreased tumor growth. HLA-A*0201 is an MHC class I molecule that presents antigenic peptides to CD8+ T cells; epitope design restricted to epitopes that bind most efficiently to HLA-A*0201 may improve antigenic peptide immunogenicity.

单词	HLA-A*0201-restricted VEGFR1 peptide vaccine
释义	HLA-A0201-restricted VEGFR1 peptide vaccine A cancer vaccine containing an HLA-A0201-restricted vascular endothelial growth factor receptor 1 (VEGFR1) peptide (sequence: TLFWLLLTL) with potential immunostimulatory and antitumor activities. Upon administration, HLA-A0201-restricted VEGFR1-derived peptide vaccine may stimulate a cytotoxic T lymphocyte (CTL) response against tumor cells expressing VEGFR1, resulting in tumor cell lysis and decreased tumor growth. HLA-A0201 is an MHC class I molecule that presents antigenic peptides to CD8+ T cells; epitope design restricted to epitopes that bind most efficiently to HLA-A*0201 may improve antigenic peptide immunogenicity.
随便看	kunecatechins ointment KW-2149 KW2189 KX2-391 Kynacyte kyphosis Kyprolis Kyprolis Kytril L19-IL2 monoclonal antibody-cytokine fusion protein L-3,5,5’-tetraiodothyronine L-377,202 L-377,202 L-778,123 labetuzumab-SN-38 immunoconjugate IMMU-130 labial mucosa LaBID lab-on-a-chip laboratory study laboratory test lacosamide lacrimal gland lactase lactate dehydrogenase lacteal